- Home
- JEQ vs EPIX Comparison
JEQ vs EPIX Comparison
Compare JEQ & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- EPIX
- Stock Information
- Founded
- JEQ 1990
- EPIX 2009
- Country
- JEQ United States
- EPIX Canada
- Employees
- JEQ N/A
- EPIX N/A
- Industry
- JEQ Air Freight/Delivery Services
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- JEQ Consumer Discretionary
- EPIX Health Care
- Exchange
- JEQ Nasdaq
- EPIX Nasdaq
- Market Cap
- JEQ 88.1M
- EPIX 75.9M
- IPO Year
- JEQ N/A
- EPIX N/A
- Fundamental
- Price
- JEQ $7.13
- EPIX $1.72
- Analyst Decision
- JEQ
- EPIX Hold
- Analyst Count
- JEQ 0
- EPIX 3
- Target Price
- JEQ N/A
- EPIX $2.00
- AVG Volume (30 Days)
- JEQ 32.0K
- EPIX 68.7K
- Earning Date
- JEQ 01-01-0001
- EPIX 08-04-2025
- Dividend Yield
- JEQ 7.05%
- EPIX N/A
- EPS Growth
- JEQ N/A
- EPIX N/A
- EPS
- JEQ N/A
- EPIX N/A
- Revenue
- JEQ N/A
- EPIX N/A
- Revenue This Year
- JEQ N/A
- EPIX N/A
- Revenue Next Year
- JEQ N/A
- EPIX N/A
- P/E Ratio
- JEQ N/A
- EPIX N/A
- Revenue Growth
- JEQ N/A
- EPIX N/A
- 52 Week Low
- JEQ $4.99
- EPIX $1.40
- 52 Week High
- JEQ $6.39
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- JEQ 52.12
- EPIX 55.34
- Support Level
- JEQ $7.08
- EPIX $1.60
- Resistance Level
- JEQ $7.87
- EPIX $1.73
- Average True Range (ATR)
- JEQ 0.12
- EPIX 0.04
- MACD
- JEQ -0.03
- EPIX 0.00
- Stochastic Oscillator
- JEQ 5.70
- EPIX 76.50
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.